Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Consomic
100%
Pulmonary Hypertension
100%
Pulmonary Arterial Hypertension
100%
Genomic Studies
100%
Rodent Models
100%
Rodents
37%
Sorafenib
37%
Severe Pulmonary Arterial Hypertension
25%
Modifier Genes
25%
Genetic Basis
25%
Bone Morphogenetic Protein Receptor Type 2
25%
Specific Aims
25%
Bone Morphogenetic Protein Receptor
25%
Gene Expression Profiling
12%
Environmental Factors
12%
Therapeutic Pathways
12%
Vascular Endothelial Growth Factor Receptor Inhibitor
12%
Disease Outcome
12%
Strain Background
12%
Novel Therapeutics
12%
Severe Pulmonary Hypertension
12%
Translational Research
12%
Attenuation
12%
Genetic Polymorphism
12%
Gene mutation
12%
In(III)
12%
Vascular Reactivity
12%
Responsive Genes
12%
SU5416
12%
Fatal Outcome
12%
Single Chromosome
12%
Chronic Hypoxia
12%
Multikinase Inhibitor
12%
Novel Target Gene
12%
Consomic Rat
12%
Biochemistry, Genetics and Molecular Biology
Chromosome
100%
Sorafenib
100%
Genomics
100%
Genetics
66%
Bone Morphogenetic Protein Receptor Type 2
66%
Candidate Gene
66%
Modifier Gene
66%
Rat
66%
Genetic Polymorphism
33%
Gene Mutation
33%
Gene Expression Profiling
33%
Phosphotransferase
33%
Kinase
33%
VEGF Receptors
33%
Blood Vessel Reactivity
33%
Growth Factor Receptor Inhibitor
33%
Semaxanib
33%
Immunology and Microbiology
Sorafenib
100%
Chromosome
100%
Bone Morphogenetic Protein Receptor Type 2
66%
Modifier Gene
66%
Rat
66%
Gene Mutation
33%
Genetic Polymorphism
33%
Semaxanib
33%
Blood Vessel Reactivity
33%
Vasculotropin
33%
Susceptibility
33%
Gene Expression Assay
33%
Kinase
33%
Phosphotransferase
33%